Small Pharma Inc (DMT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 02-2023 | 02-2022 | 02-2021 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 48 | 20 | 6 |
| Accounts receivable | 350 | -764 | -247 |
| Other Working Capital | -655 | 1,515 | 763 |
| Other Operating Activity | -21,954 | -17,007 | -4,771 |
| Operating Cash Flow | $-22,211 | $-16,235 | $-4,249 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -19 | -13 | -71 |
| Net Acquisitions | 0 | 109 | 0 |
| Other Investing Activity | 2,489 | -2,500 | 0 |
| Investing Cash Flow | $2,471 | $-2,404 | $-71 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 0 | 9,309 |
| Debt Repayment | -13 | N/A | N/A |
| Common Stock Issued | 0 | 53,799 | 98 |
| Common Stock Repurchased | -483 | N/A | N/A |
| Other Financing Activity | 60 | 91 | 0 |
| Financing Cash Flow | $-436 | $53,891 | $9,408 |
| Exchange Rate Effect | -1,943 | -374 | 128 |
| Beginning Cash Position | 40,656 | 5,778 | 563 |
| End Cash Position | 18,537 | 40,656 | 5,778 |
| Net Cash Flow | $-20,177 | $35,252 | $5,087 |
| Free Cash Flow | |||
| Operating Cash Flow | -22,211 | -16,235 | -4,249 |
| Capital Expenditure | -29 | -13 | -71 |
| Free Cash Flow | -22,240 | -16,248 | -4,320 |